Introduction
The treatment of pneumothorax depends on the size of the air leak, the severity of symptoms, and whether the accumulated air is interfering with lung expansion or cardiovascular function. The main approaches are observation, supplemental oxygen, needle aspiration, chest tube drainage, and surgery. These treatments work by either helping the pleural air reabsorb, removing air from the pleural space, sealing the defect that allowed air to enter, or preventing recurrence. In all cases, the aim is to restore the negative pressure between the lung and chest wall so the lung can re-expand and normal breathing mechanics can return.
Pneumothorax occurs when air enters the pleural space, the thin fluid-containing cavity between the visceral pleura covering the lung and the parietal pleura lining the chest wall. This disrupts the vacuum-like pressure that normally keeps the lung expanded. Treatment therefore focuses on reversing that pressure imbalance and, when needed, repairing the source of the leak.
Understanding the Treatment Goals
The central goals of treatment are to reduce breathlessness and chest pain, prevent further accumulation of pleural air, and restore normal lung expansion. A smaller pneumothorax may resolve if the air in the pleural space is allowed to reabsorb naturally, whereas a larger one may compress the lung enough to impair ventilation and gas exchange. In that setting, treatment must actively remove the air or decompress the chest.
Another major goal is to address the biological cause of the air leak. In some cases, a ruptured bleb or bulla on the lung surface allows alveolar air to escape into the pleural cavity. In others, trauma, medical procedures, or underlying lung disease create a defect that must be closed or bypassed. Preventing recurrence is also part of treatment planning, especially when the pleural injury is likely to happen again or when repeated episodes could progressively damage lung function.
Common Medical Treatments
Observation is used when the pneumothorax is small and the person is clinically stable. The body absorbs pleural air gradually because gases move down their pressure gradients across the pleural membranes into the bloodstream. As the pleural air volume decreases, the pressure outside the lung falls, allowing elastic recoil of the lung and chest wall to re-establish the normal apposition of the pleural layers. This approach targets the natural resorption process rather than actively removing air.
Supplemental oxygen is often used to accelerate pleural air reabsorption. Breathing oxygen lowers the amount of nitrogen in the alveoli and blood. Since the trapped pleural air is rich in nitrogen, the reduction in blood nitrogen increases the diffusion gradient for nitrogen to leave the pleural space and enter the circulation. This shortens the time needed for the collection of air to shrink. Oxygen does not seal the leak directly, but it supports faster physiologic resolution of the pneumothorax.
Needle aspiration removes air through a catheter or needle placed into the pleural space. By actively extracting pleural gas, it reduces intrapleural pressure and allows the lung to re-expand. This treatment addresses the immediate mechanical problem: compressed lung tissue cannot ventilate effectively until the air pocket is reduced. Aspiration is typically used when prompt decompression is needed but the pneumothorax is not so large or persistent that continuous drainage is required.
Pain control is another common component of medical care, although it does not treat the pneumothorax itself. Pleuritic pain arises because the parietal pleura is richly innervated, and stretching or irritation from pleural air can activate pain fibers. Analgesia improves chest wall movement and reduces splinting, which can otherwise impair ventilation. By limiting shallow breathing caused by pain, symptom control supports more effective lung expansion.
Procedures or Interventions
Chest tube drainage, also called tube thoracostomy, is used when the pneumothorax is larger, symptomatic, recurrent, traumatic, or not resolved by simple aspiration. A tube is inserted into the pleural space and connected to a one-way drainage system. Air escapes through the tube as it leaves the pleural cavity, but re-entry is prevented. This creates a path for the trapped gas to exit continuously, allowing the pleural pressure to return toward normal and the lung to re-expand more completely.
This intervention is particularly useful when the air leak persists, because the system can keep removing gas as long as it is entering the pleural space. In physiologic terms, the tube reduces the pressure burden on the lung while the visceral pleural defect heals. If fluid or blood is also present, the same drainage system can remove those materials and improve lung mechanics further.
In a tension pneumothorax, emergency decompression is required because one-way air trapping causes progressive pressure buildup in the pleural space. The rising pressure compresses the lung and can shift mediastinal structures, impairing venous return to the heart and reducing cardiac output. Immediate needle decompression or chest tube placement relieves the pressure gradient quickly. The purpose is not just to re-expand the lung but to reverse life-threatening interference with circulation.
Surgical treatment is considered when pneumothorax recurs, air leaks persist, or structural lung disease makes recurrence likely. Procedures may include thoracoscopy with removal of ruptured blebs or bullae, pleural abrasion, or pleurodesis. Pleurodesis intentionally induces adherence between the visceral and parietal pleura by creating inflammation and fibrous scarring. Once the pleural layers are fused, there is no potential space for air to accumulate, which reduces the chance of another pneumothorax. Surgery therefore addresses both the site of leakage and the anatomy that allows recurrence.
In traumatic pneumothorax, treatment may also involve repair of associated chest injuries. When the chest wall is disrupted, air may enter the pleural space externally through the wound. Closing the defect, stabilizing the chest, and draining the pleural cavity restore the integrity of the thoracic enclosure. The physiologic goal remains the same: re-establish a sealed pleural environment so normal pressure relationships can resume.
Supportive or Long-Term Management Approaches
Follow-up imaging is commonly used to confirm that the lung has re-expanded and that no ongoing air accumulation is occurring. Repeat assessment helps determine whether the pleural leak has closed or whether further intervention is needed. Monitoring is part of management because the rate of reabsorption, the size of the residual pneumothorax, and the chance of recurrence vary among patients and pneumothorax types.
Long-term management may include treatment of underlying lung disorders that predispose to pneumothorax. Conditions such as chronic obstructive pulmonary disease, cystic lung disease, or asthma-related hyperinflation can weaken lung tissue or increase the risk of alveolar rupture. Managing those diseases reduces mechanical stress on fragile areas of the lung and lowers the likelihood of future pleural air leaks. In this sense, the pneumothorax is not treated in isolation; the underlying pulmonary environment is also addressed.
For recurrent spontaneous pneumothorax, preventive strategies often center on pleural symphysis or surgical correction of blebs. These approaches alter the pleural anatomy so a future air leak is less likely to produce a clinically significant collapse. Long-term management therefore aims to change the structural conditions that permit recurrence rather than only treating each episode as it appears.
Factors That Influence Treatment Choices
Severity is one of the most important determinants of treatment. A small pneumothorax in a stable person may resolve with observation and oxygen, while a larger or symptomatic one usually requires aspiration or chest tube drainage. The size of the pleural air collection matters because more air produces greater loss of negative intrapleural pressure and greater compression of the lung.
The type of pneumothorax also affects treatment selection. A primary spontaneous pneumothorax occurs without obvious underlying lung disease, whereas a secondary spontaneous pneumothorax arises in the context of diseased lungs. Secondary cases are often less physiologically tolerated because the remaining lung reserve is already reduced. Traumatic and iatrogenic pneumothoraces involve direct structural injury, so management may need to address the injury itself in addition to removing pleural air.
Age, general health, and previous episodes matter because they influence healing and recurrence risk. A younger person with an isolated small pneumothorax may have a different management path from an older person with emphysema or another chronic lung disorder. Prior failure of conservative treatment, or repeated collapse on the same side, often shifts treatment toward more definitive interventions such as surgery or pleurodesis. The choice reflects whether the problem is likely to resolve spontaneously or whether the pleural defect is persistent or anatomically predisposed to recur.
Potential Risks or Limitations of Treatment
Observation and oxygen therapy have limitations because they rely on the body’s own ability to resorb pleural air. If the leak continues or the lung collapses further, conservative treatment may be insufficient. The main risk is delayed recognition of progression, particularly if the pneumothorax enlarges faster than it resolves.
Needle aspiration and chest tube placement carry procedural risks because they involve entry into the pleural space. These include bleeding, infection, injury to lung tissue, and pain. A chest tube can also become blocked or displaced, which reduces drainage effectiveness and may allow air to reaccumulate. These risks arise from the need to breach the chest wall in order to restore normal pleural pressure.
Surgical approaches are more definitive but also more invasive. They can cause postoperative pain, bleeding, anesthetic complications, and pleural scarring. Pleurodesis intentionally creates scarring, which is therapeutic in this context but also represents a permanent alteration of pleural mechanics. In patients with limited lung reserve, even successful treatment may not fully restore baseline respiratory function if the underlying disease remains severe.
The largest biologic limitation in pneumothorax treatment is that no intervention is complete unless the air leak stops. Removing pleural air without allowing the defect to heal may provide only temporary relief. For this reason, treatment is often staged: immediate decompression if needed, followed by measures to keep the pleural space empty while the injury seals, and then recurrence prevention when indicated.
Conclusion
Treatment of pneumothorax centers on correcting the abnormal presence of air in the pleural space and restoring the negative pressure needed for lung expansion. Small, stable cases may resolve through natural reabsorption, often aided by oxygen. Larger, symptomatic, persistent, or dangerous cases require aspiration, chest tube drainage, or urgent decompression. Surgery and pleurodesis are used when the underlying anatomy or recurrence risk makes a more durable solution necessary.
Across all approaches, the same physiological principles apply: reduce pleural air, relieve pressure on the lung, allow the pleural defect to heal, and prevent the air from reaccumulating. The choice of treatment depends on how much the lung is compressed, whether the leak is ongoing, and whether the individual has underlying disease that changes the balance between spontaneous recovery and procedural intervention.